Jump to content

TC-1698: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
PotatoBot (talk | contribs)
m Stub sorting and placement of stub template(s): nervous-system-drug-stub. See approval. Report errors and suggestions at User talk:PotatoBot.
CheMoBot (talk | contribs)
Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia
Line 8: Line 8:
| ATC_suffix=
| ATC_suffix=
| PubChem= 10130417
| PubChem= 10130417
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank=
| DrugBank=
| C=13 | H=18 | N=2
| C=13 | H=18 | N=2

Revision as of 20:09, 10 September 2011

TC-1698
Legal status
Legal status
  • In general: legal
Identifiers
  • 2-pyridin-3-yl-1-azabicyclo[3.2.2]nonane
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H18N2
Molar mass202.295 g·mol−1
3D model (JSmol)
  • c2ncccc2C1CCC3CCN1CC3
  (verify)

TC-1698 is a drug developed by Targacept which acts as a partial agonist for the α7 subtype of neural nicotinic acetylcholine receptors.[1] It has neuroprotective effects in animal studies,[2] and has been used as a lead compound to find further potent derivatives.[3]

References

  1. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17295372, please use {{cite journal}} with |pmid=17295372 instead.
  2. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14722323, please use {{cite journal}} with |pmid=14722323 instead.
  3. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18363376, please use {{cite journal}} with |pmid=18363376 instead.


Template:Nootropics